Juan M. Barajas

Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model

Kun‐Yu Teng, Jianfeng Han, Xiaoli Zhang et al. · Molecular Cancer Therapeutics · 2016 · 132 citations · Full text

Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer

Joseph M. Luna, Juan M. Barajas, Kun‐Yu Teng et al. · Molecular Cell · 2017 · 82 citations · Full text

Tumor Biology, Human Liver Cancer, Deregulated Mir-122-bound Transcriptome +14

The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer

Juan M. Barajas, Ryan Reyes, Maria J. Guerrero et al. · Scientific Reports · 2018 · 73 citations · Full text

Acute myeloid leukemias with <i>UBTF</i> tandem duplications are sensitive to menin inhibitors

Juan M. Barajas, Milad Rasouli, Masayuki Umeda et al. · Blood · 2023 · 48 citations · Full text

A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma

Aaron B. Koenig, Juan M. Barajas, Maria J. Guerrero et al. · International Journal of Molecular Sciences · 2018 · 42 citations · Full text